Option Care Health, Inc. (OPCH)

Market Cap	4.46B -21.3%
Revenue (ttm)	5.65B +13.0%
Net Income	207.59M -2.0%
EPS	1.27 +3.3%
Shares Out	156.45M
PE Ratio	22.17
Forward PE	18.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257,356
Open	28.74
Previous Close	28.16
Day's Range	28.42 - 28.93
52-Week Range	24.24 - 36.80
Beta	0.88
Analysts	Strong Buy
Price Target	37.00 (+29.92%)
Earnings Date	Apr 28, 2026

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arth...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John Rademacher
• Employees: 8,266
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH
• Website: https://optioncarehealth.com

Financial Performance

In 2025, Option Care Health's revenue was $5.65 billion, an increase of 13.03% compared to the previous year's $5.00 billion. Earnings were $207.59 million, a decrease of -2.00%.

Analyst Summary

According to 8 analysts, the average rating for OPCH stock is "Strong Buy." The 12-month stock price target is $37.0, which is an increase of 29.92% from the latest price.

Price Target

$37.0

(29.92% upside)

Analyst Consensus: Strong Buy